Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Hepatocellular 6Drug-Related Side Effects and Adverse Reactions 2Colorectal Neoplasms 2Advanced Gastric Cancer 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Quality of Life 1Peritoneal Metastases From Gastric Cancer 1Ovarian Cancer Recurrent 1Osteosarcoma 1Meningioma 1Immune Checkpoint Inhibition 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Chondrosarcoma 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Adenocarcinoma 1

Interventions

apatinib 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Ovarian Cancer Recurrent × apatinib × Clear all
NCT06102707 2023-10-26

The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

Qilu Hospital of Shandong University

Phase NA Not yet recruiting
50 enrolled
Gynecologic

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡